Bush Generic Rx Proposal Has PhRMA Backing As Alternative To Legislation
Executive Summary
The Pharmaceutical Research & Manufacturers of America is expected to endorse the Bush Administration's proposed generic drug reforms as an alternative to a Congressional reopening of Waxman/Hatch
You may also be interested in...
DTC Ads Remain Controversial Despite Positive Study Results, PhRMA Says
The Pharmaceutical Research & Manufacturers of America is prepared to use the results of recent direct-to-consumer advertising studies to respond to critics of the marketing practice
DTC Ads Remain Controversial Despite Positive Study Results, PhRMA Says
The Pharmaceutical Research & Manufacturers of America is prepared to use the results of recent direct-to-consumer advertising studies to respond to critics of the marketing practice
PhRMA Wants Amended ANDAs To Trigger 30-Month Stays
FDA should specify that ANDAs which change certification from Paragraph III to Paragraph IV should trigger for a 30-month stay, the Pharmaceutical Research & Manufacturers of America states in comments on FDA's proposed rule